Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $50,000,021 |
Sells | 208 | $144,175,591 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
06 Dec 2023 18:13 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 04 Dec 2023 | Sale | 681 | 12.01 | 8,179 | D |
13 Dec 2022 17:05 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 12 Dec 2022 | Sale | 751 | 10.87 | 8,163 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 08 Mar 2024 | Sale | 291 | 27.41 | 7,976 | D |
12 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 08 Mar 2024 | Sale | 289 | 27.33 | 7,898 | D |
13 Dec 2022 17:03 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 12 Dec 2022 | Sale | 680 | 10.87 | 7,392 | D |
13 Dec 2022 17:04 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 12 Dec 2022 | Sale | 628 | 10.87 | 6,826 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 210 | 25.25 | 5,302 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 210 | 25.25 | 5,302 | I |
13 Dec 2022 17:05 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 12 Dec 2022 | Sale | 472 | 10.87 | 5,131 | D |
26 Jan 2024 19:48 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 26 Jan 2024 | Sale | 178 | 25.14 | 4,475 | D |
13 Dec 2022 17:06 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 12 Dec 2022 | Sale | 312 | 10.87 | 3,391 | D |
26 Jan 2024 19:49 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 26 Jan 2024 | Sale | 100 | 25 | 2,500 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)